Back
New York Community Bancorp Vs. Mirum Pharmaceuticals Industry Stock Comparison
Sell
36
NYCB
New York Community Bancorp
Last Price:
12.00
Seasonality Move:
1.12%
Sell
40
MIRM
Mirum Pharmaceuticals
Last Price:
39.35
Seasonality Move:
5.99%
Sell
36
New York Community Bancorp (NYCB)
is a Sell
Is New York Community Bancorp a Buy, Sell or Hold?
- The current New York Community Bancorp [NYCB] share price is $11.92. The Score for NYCB is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- NYCB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Mirum Pharmaceuticals (MIRM)
is a Sell
Is Mirum Pharmaceuticals a Buy, Sell or Hold?
- The current Mirum Pharmaceuticals [MIRM] share price is $37.93. The Score for MIRM is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- MIRM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NYCB Stock Price Chart
What is New York Community Bancorp's stock price today?
-
The New York Community Bancorp share price today is $11.92
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NYCB is experiencing slight selling pressure.
MIRM Stock Price Chart
What is Mirum Pharmaceuticals's stock price today?
-
The Mirum Pharmaceuticals share price today is $37.93
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MIRM is experiencing slight selling pressure.
NYCB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.24 | Buy |
Relative Strength Index (14 RSI): | 63.27 | Buy |
Chaikin Money Flow: | -3996942 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (10.24 - 11.3) | Buy |
Bollinger Bands (100): | (9.47 - 11.03) | Buy |
MIRM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.13 | Sell |
Relative Strength Index (14 RSI): | 36.81 | Sell |
Chaikin Money Flow: | -512602 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (40.29 - 42.71) | Sell |
Bollinger Bands (100): | (27.1 - 41.32) | Buy |
NYCB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 10.83 | Buy |
20-day SMA: | 10.78 | Buy |
50-day SMA: | 10.6 | Buy |
200-day SMA: | 14.69 | Sell |
8-day EMA: | 11.15 | Buy |
20-day EMA: | 10.81 | Buy |
50-day EMA: | 10.59 | Buy |
200-day EMA: | 14.66 | Sell |
MIRM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 40.68 | Sell |
20-day SMA: | 41.55 | Sell |
50-day SMA: | 40.65 | Sell |
200-day SMA: | 31.03 | Buy |
8-day EMA: | 40.34 | Sell |
20-day EMA: | 40.95 | Sell |
50-day EMA: | 39.41 | Sell |
200-day EMA: | 32.8 | Buy |
New York Community Bancorp Earnings Growth & NYCB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $1.45 per share, an increase next quarter of $0.48 per share, a decrease this year of $6.31 per share, and an increase next year of $2.37 per share.
Mirum Pharmaceuticals Earnings Growth & MIRM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.38 per share, an increase next quarter of $0.30 per share, an increase this year of $1.79 per share, and an increase next year of $0.88 per share.
New York Community Bancorp Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Mirum Pharmaceuticals Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |